Product Details
668273-75-4
(3R)-1-[7-(2-Butynyl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]carbamic acid 1,1-dimethylethyl ester
GSN Code
GLGT02101
CAS No
668273-75-4
API Name
Linagliptine
Therapeutic Area
Diabetes mellitus type 2